Publications by authors named "Mitsuaki Shimada"
Article Synopsis
- * It compared incidents of adverse reactions in new users of pemafibrate (1294 patients) with users of fenofibrate (508 patients), finding that pemafibrate users had increased blood pressure as a notable side effect.
- * The results underline the importance of monitoring drug safety and suggest that more studies are needed to assess newly marketed drugs effectively in Japan.
Background: We aimed to discuss and compare reported adverse reactions and drug add-ons associated with elobixibat and lubiprostone use in chronic constipation treatment, as the safety of these drugs has not been well examined in post-marketing clinical settings.
Research Design And Methods: In this retrospective cohort study, using records of community pharmacies in Japan, we identified new users of elobixibat and lubiprostone. The Japan Pharmaceutical Association sent questionnaires regarding baseline and event data to community pharmacists.
We conducted a workshop that aimed to address the problems of collaboration between community and hospital pharmacists to provide safe outpatient chemotherapy and promote continuous collaboration. Thirty-nine pharmacists in Gunma were enrolled in the workshop and divided into five groups. Each group comprised similar number of community and hospital pharmacists in the neighboring area.
View Article and Find Full Text PDF